From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles.

Autor: Colbert Maresso K; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Maitra A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hawk ET; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2023 Jul 05; Vol. 16 (7), pp. 365-367.

AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.

Autor: Lippman SM; UC San Diego Moores Cancer Center, LaJolla, California. ehawk@mdanderson.org slippman@ucsd.edu., Abate-Shen C; Departments of Urology, Medicine, Systems Biology, and Pathology & Cell Biology, Institute of Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY., Colbert Maresso KL; Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX., Colditz GA; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri., Dannenberg AJ; Weill Cornell Medical College, New York, NY., Davidson NE; Fred Hutchinson Cancer Center and University of Washington, Seattle, Washington., Disis ML; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington., DuBois RN; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina., Szabo E; Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland., Giuliano AR; Center for Infection Research in Cancer, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Hait WN; Janssen Research and Development LLC., Raritan, New Jersey., Lee JJ; Department of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, Texas., Kensler TW; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Kramer BS; Division of Cancer Prevention, NCI, Bethesda, Maryland., Limburg P; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Maitra A; Sheikh Ahmed Pancreatic Cancer Research Center, University of Texas MD Anderson Cancer Center, Houston, TX., Martinez ME; Department of Family Medicine and Public Health, UC San Diego, LaJolla, California., Rebbeck TR; Cancer Epidemiology & Cancer Risk and Disparity, Dana-Farber Cancer Institute, Boston, MA., Schmitz KH; College of Medicine, Pennsylvania State University, Hershey, PA., Vilar E; Departments of Clinical Cancer Prevention and GI Medical Oncology, UT MD Anderson Cancer Center, Houston, TX., Hawk ET; Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX. ehawk@mdanderson.org slippman@ucsd.edu.

Publikováno v: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2018 Dec; Vol. 11 (12), pp. 735-778.

Cancer chemoprevention: successes and failures.

Autor: Patterson SL; Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colbert Maresso K, Hawk E

Publikováno v: Clinical chemistry [Clin Chem] 2013 Jan; Vol. 59 (1), pp. 94-101. Date of Electronic Publication: 2012 Nov 13.